Clobazam and Pulmonary embolism - a phase IV clinical study of FDA data

Summary:

Pulmonary embolism is reported as a side effect among people who take Clobazam (clobazam), especially for people who are male, 20-29 old, also take Cannabis, and have Epilepsy.

The phase IV clinical study analyzes which people have Pulmonary embolism when taking Clobazam. It is created by eHealthMe based on reports of 14,346 people who have side effects when taking Clobazam from the FDA, and is updated regularly.

What is Clobazam?

Clobazam has active ingredients of clobazam. eHealthMe is studying from 14,399 Clobazam users. Check the latest studies of Clobazam.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,333 drugs and 2,956 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

On Jul, 05, 2026

14,346 people reported to have side effects when taking Clobazam.
Among them, 38 people (0.26%) have Pulmonary embolism.

Could Clobazam cause Pulmonary embolism?

Among these 38 people:

What is the gender of people who have Pulmonary embolism when taking Clobazam? *

female: 36.11 %
male: 63.89 %

What is the age of people who have Pulmonary embolism when taking Clobazam? *

What are other drugs people take besides Clobazam? *

Cannabis: 10 people, 26.32%
Sodium Bicarbonate: 6 people, 15.79%
Keppra: 5 people, 13.16%
Paroxetine: 5 people, 13.16%
Pantoprazole: 5 people, 13.16%
Ceftriaxone Sodium: 4 people, 10.53%
Folic Acid: 4 people, 10.53%
Plavix: 4 people, 10.53%
Paroxetine Hydrochloride: 4 people, 10.53%
Bisoprolol Fumarate: 4 people, 10.53%

What are other side effects people have besides Pulmonary embolism? *

Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 9 people, 23.68%
Pneumonia Necrotising (necrotizing pneumonia is a life-threatening condition in which a person breathes material into his or her lungs): 9 people, 23.68%
Cardiac Arrest: 9 people, 23.68%
Head Injury: 7 people, 18.42%
Rickets (softening of bones): 6 people, 15.79%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 5 people, 13.16%
Bradycardia (abnormally slow heart action): 4 people, 10.53%
Fatigue (feeling of tiredness): 4 people, 10.53%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 4 people, 10.53%
Fever: 4 people, 10.53%

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 10 people, 26.32%
Insomnia (sleeplessness): 7 people, 18.42%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 15.79%
High Blood Pressure: 6 people, 15.79%
Fever: 6 people, 15.79%
Depression: 6 people, 15.79%
Partial Seizures (seizures which affect only a part of the brain at onset): 5 people, 13.16%
Anaemia (lack of blood): 5 people, 13.16%
Device Related Infection: 4 people, 10.53%
Dyslipidaemia (abnormal amount of lipids): 4 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Clobazam and have Pulmonary embolism?

- Check whether Pulmonary embolism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clobazam:

Clobazam (14,399 reports)

Browse all side effects of Clobazam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary embolism:

Pulmonary embolism (2,333 drugs)

Browse all the conditions that are associated with Pulmonary embolism:

Pulmonary embolism (2,956 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clobazam (the active ingredients of Clobazam) and Clobazam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.